RNA-activated DNA cleavage by the Type III-B CRISPR-Cas effector complex

Genes Dev. 2016 Feb 15;30(4):460-70. doi: 10.1101/gad.273722.115. Epub 2016 Feb 4.

Abstract

The CRISPR (clustered regularly interspaced short palindromic repeat) system is an RNA-guided immune system that protects prokaryotes from invading genetic elements. This system represents an inheritable and adaptable immune system that is mediated by multisubunit effector complexes. In the Type III-B system, the Cmr effector complex has been found to cleave ssRNA in vitro. However, in vivo, it has been implicated in transcription-dependent DNA targeting. We show here that the Cmr complex from Thermotoga maritima can cleave an ssRNA target that is complementary to the CRISPR RNA. We also show that binding of a complementary ssRNA target activates an ssDNA-specific nuclease activity in the histidine-aspartate (HD) domain of the Cmr2 subunit of the complex. These data suggest a mechanism for transcription-coupled DNA targeting by the Cmr complex and provide a unifying mechanism for all Type III systems.

Keywords: CMR; CRISPR–Cas; RAMP; RNA; nuclease.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Bacterial Proteins / genetics
  • Bacterial Proteins / metabolism
  • CRISPR-Cas Systems / physiology*
  • DNA Cleavage*
  • Deoxyribonucleases / metabolism
  • Enzyme Activation
  • Protein Binding
  • Protein Structure, Tertiary
  • RNA, Bacterial / metabolism
  • Thermotoga maritima / genetics*
  • Thermotoga maritima / metabolism*

Substances

  • Bacterial Proteins
  • RNA, Bacterial
  • Deoxyribonucleases